The head of the World Health Organization urged countries on Thursday to contribute resources that can expedite products which may help stem the coronavirus pandemic.
The WHO’s ACT-Accelerator programme already supports research into potential vaccines, drugs and diagnostics, WHO Director-General Tedros Adhanom Ghebreyesus told an online event.
“But we need to rapidly scale up our clinical trials, manufacturing, licensing and regulation capacity so that these products can get to people and start saving lives,” he said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
No Mickey's Christmas party this year: Disney World cancels some holiday events due to COVID-19Disney World fans, you may want to take a deep breath for this one. The holidays are going to look different this year due to the pandemic.
Weiterlesen »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Weiterlesen »
Why AstraZeneca pausing its COVID-19 vaccine trial may be good newsAstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.'
Weiterlesen »
AstraZeneca's COVID-19 vaccine trial has been stopped after an illnessIt may seem surprising to stop a multimillion-dollar, 30,000-person trial because one person fell ill, but 'it's not at all unprecedented,' said Dr. Francis Collins, director of the National Institutes of Health. Here's what we know.
Weiterlesen »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Weiterlesen »
COVID-19 Vaccine Trial Paused, Due To Illness In One VolunteerDrugmaker AstraZeneca says it's pausing its COVID-19 vaccine trial because of a 'potentially unexplained illness' in one of the trial volunteers. A safety review will be conducted to determine if it's a chance event or somehow related to the vaccine.
Weiterlesen »